BH, Inc.

BH, Inc. Britz & CO. Division, doing business as Britz & Company, manufactures specialized animal research caging and biocontainment equipment for federal life-sciences research agencies as a prime contractor, holding self-certified small disadvantaged business status. Based in Sheridan, Wyoming, the vendor operates across NAICS categories centered on fabricated metal products and laboratory equipment manufacturing (23 awards under Other Fabricated Wire Product Manufacturing; 16 under All Other Miscellaneous Fabricated Metal Product Manufacturing) and delivers primarily under PSC Laboratory Equipment and Supplies (39 awards) and Medical and Surgical Instruments, Equipment, and Supplies (7 awards).

Britz & Company's federal footprint spans 81 prime purchase orders over three decades with no subcontract activity. The vendor competes full-and-open without set-aside designation across most awards, though one NIDA purchase order was set aside for total small businesses. Customer concentration is diffuse across 24 distinct agencies, but the National Institutes of Health (multiple institutes) account for 21 awards (26% of the portfolio) representing approximately $232 thousand combined potential value. Within NIH, the National Institute on Drug Abuse (NIDA) leads with 9 awards valued at $149 thousand, focused on rhesus macaque and non-human primate housing. By potential value, the Centers for Disease Control and Prevention (7 awards, $1.061 million combined), the Department of the Army Medical Command (4 awards, $303 thousand), and the Department of Veterans Affairs Veterans Health Administration (4 awards, $477 thousand combined across two service networks) dominate the dollar rankings — a divergence from award-count concentration that reflects higher-dollar medical equipment procurements outside the NIH cluster.

Named recent work includes a $85,665 National Heart, Lung, and Blood Institute purchase order (September 2026, performance in Sheridan) to renovate animal facility containment cubicles at NHLBI's Central Animal Facility in Bethesda, Maryland; a $43,649.90 Defense Health Agency purchase order (July 2025) for marmoset cages on behalf of AFRIMS Thailand; and a $38,320 NIDA total-small-business set-aside (September 2023) for five non-human primate apartment modules. The vendor operates under three blanket purchase agreements (one task order each). Activity has declined from a peak of four awards in 2021 to one in 2026; only one award (combined potential value $86 thousand) reaches ultimate completion within the next twenty-four months, yielding minimal recompete exposure in the near term. Combined obligated dollars across the portfolio ($5.2 million) exceed combined potential value ($3.1 million), indicating invoiced revenue in excess of contract ceilings across the lifecycle.

Animal Caging, Restraint, Transport and Management Equipment for supporting biomedical and animal research.